stocktools
Dilution profile // every instrument, one screen, from SEC filings

CollPlant Biotechnologies Ltd (CLGN)

CIK 1631487 · all EDGAR filings →

Overall dilution risk
HIGHworst of 4 computed sub-ratings (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
Offering ability
HIGH$113M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
registered capacity, not remaining: amounts already taken down are not subtracted yet
Overhead supply
LOWwarrants = 1% of O/S
= warrant shares outstanding divided by current shares outstanding (bands: 20% / 50%)
warrants only; converts, ATMs and equity lines are not in free structured data, so the true overhead is AT LEAST this
Historical dilution
LOW+14% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
MEDIUM~7.1 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2017-12-312025-12-31

Latest: 12.8M shares as of Dec 31, 2025 (20-F).

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2025-12-31
HowThe newest cover-page count as filed. It is used as the current count only while it is no more than about 15 months older than the company’s newest periodic filing; the float checker applies a 200-day rule and sets it beside the balance-sheet count.
Open the source document →
Share count fell from 190.7M to 5.7M between Dec 31, 2018 and Dec 31, 2019, a pattern consistent with a reverse split (roughly 1-for-34); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

~7 months of cash left

burning $2.4M / quarter

Full breakdown: cash runway tool

Warrants

Warrants outstanding: 126,800 underlying shares, as reported Jun 30, 2024 (6-K).

Reported exercise price: $3.75 (aggregate figure as tagged; individual tranches vary).

Rough fully diluted estimate: 12.9M = 12.8M O/S + 126,800 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Fully diluted build-up

Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.

Shares outstanding12.8MDec 31, 2025
+ Warrants (aggregate, as tagged) (if exercised)126,800Jun 30, 2024
Fully diluted estimate12.9M+1.0% vs O/S

Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.

Registrations and offerings

Registered offering capacity on live registrations: $112.8Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3Jul 9, 2026$10.9M registeredfiling →
F-1Mar 30, 2026$2.0M registeredfiling →
F-3Jan 9, 2026$100.0M registeredfiling →

Last 12 months: 1 executed · 4 registered.

UPDATEJul 17, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEJul 16, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJul 9, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →
UPDATEApr 21, 2026Prospectus update — often a resale registration, not necessarily new capital424B3 →
EFFECTIVEApr 21, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDApr 15, 2026F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDMar 30, 2026F-1 registration — capacity to sell shares, not a sale yetF-1 →
EXECUTEDFeb 6, 2026Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVEJan 16, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDJan 9, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →
EFFECTIVEAug 28, 2025SEC declared a registration effective — selling can beginEFFECT →
UPDATEJul 3, 2025Prospectus update — often a resale registration, not necessarily new capital424B3 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full CLGN workspace

Free to use. No account, no card.